Company · ABBV
AbbVie
Last checked: Nov 19, 2026Source: Drugs@FDA, ClinicalTrials.gov
NDAs and BLAs
198
83 still marketed
Novel approvals
62
Approvals since 2021
78
Originals and new uses
Phase 3 trials
458
Registered, any status
Trials by phase
All registered drug and biologic trials with this lead sponsor, any status. A public view of the pipeline.
Recent approvals
Originals and efficacy supplements, newest first.
- Skyrizi new use Priority reviewOrphanOct 23, 2026
- Juvmo approved NovelSep 25, 2026
- Skyrizi new use OrphanJun 26, 2026
- Skyrizi new use OrphanJun 12, 2026
- Decnupaz approved NovelPriority reviewOrphanMay 27, 2026
- Linzess new use Priority reviewMay 21, 2026
- Venclexta new use OrphanMay 20, 2026
- Skyrizi new use OrphanMar 6, 2026
- Venclexta new use OrphanFeb 19, 2026
- Vraylar new use Priority reviewDec 18, 2025
Drugs in development (36)
Investigational drugs, not yet FDA-approved, in this company's active or recent Phase 2 and 3 trials. Phase 3 first.
- Telisotuzumab AdizutecanABBV-400Phase 316 trials
AbbVie · c-MET, Non-Squamous Non-Small Cell Lung Cancer, Metastatic Colorectal Cancer
- EtentamigABBV-383, TNB-383BPhase 38 trials
AbbVie · Multiple Myeloma, Relapsed or Refractory Multiple Myeloma, Amyloid Light Chain (AL) Amyloidosis
- LutikizumabABT-981Phase 38 trials
AbbVie · Hidradenitis Suppurativa, Atopic Dermatitis, Rheumatoid Arthritis
- BMS-986348CC-92480, mezigdomidePhase 37 trials
Bristol Myers Squibb · Multiple Myeloma, Relapsed or Refractory Multiple Myeloma
- BudigalimabABBV-181Phase 36 trials
AbbVie · Hepatocellular Carcinoma, Non Small Cell Lung Carcinoma, c-MET
- ABBV-706Phase 34 trials
AbbVie · Small Cell Lung Cancer, Extensive Stage-Small Cell Lung Cancer (ES-SCLC), Extensive Stage-Small Cell Lung Cancer
- AmrubicinJapan onlyPhase 34 trials
Gilead Sciences · Small Cell Lung Cancer, Extensive Stage Small Cell Lung Cancer (ES-SCLC), Small Cell Lung Cancer (SCLC)
- folinic acidPhase 34 trials
Astellas · Unresectable Metastatic Colorectal Cancer, Locally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma or Cancer, Locally Advanced Unresectable Gastric Adenocarcinoma or Cancer
- LivmoniplimabABBV-151Phase 34 trials
AbbVie · Hepatocellular Carcinoma, Urothelial Carcinoma, Non-Small Cell Lung Cancer
- ABBV-722Phase 32 trials
AbbVie · Rheumatoid Arthritis, Systemic Sclerosis
- AGN-151586Phase 32 trials
AbbVie · Forehead Lines, Glabellar Lines
- Surabgene LomparvovecABBV-RGX-314Phase 32 trials
AbbVie · Diabetic Retinopathy, Neovascular Age-related Macular Degeneration
- ABBV-1480Phase 31 trial
AbbVie · Non-Small Cell Lung Cancer
- ABBV-444Phase 31 trial
AbbVie · Dry Eye Disease
- ABBV-932Phase 23 trials
AbbVie · Bipolar I or II Disorder, Generalized Anxiety Disorder (GAD), Bipolar I Disorder
- ABBV-295Phase 22 trials
AbbVie · Obesity, Overweight, Moderate to Severe Psoriasis
- ABBV-701Phase 22 trials
AbbVie · Crohn's Disease, Ulcerative Colitis, Psoriatic Arthritis
- AGN-151607-DPPhase 22 trials
AbbVie · Ventral Hernia, Upper Limb Essential Tremor
- BRIMOCHOL PF eye dropsCARBACHOL PF eye drops, Brimonidine tartrate eye dropsPhase 22 trials
Zhaoke (Guangzhou) Ophthalmology Pharmaceutical Ltd. · Presbyopia, Recurrent Ovarian Cancer, Folate Receptor-Alpha Positive
- IcalcaprantABBV-1354, CVL-354Phase 22 trials
AbbVie · Bipolar I Disorder, Bipolar II Disorder, Major Depressive Disorder
- IMGN632Phase 22 trials
AbbVie · Blastic Plasmacytoid Dendritic Cell Neoplasm, Myeloproliferative Neoplasm, Acute Myeloid Leukemia
- TrosunilimabABBV-382Phase 22 trials
AbbVie · Crohn's Disease, Ulcerative Colitis
- ABBV-142Phase 21 trial
AbbVie · Idiopathic Pulmonary Fibrosis
- ABBV-1758Phase 21 trial
AbbVie · Alzheimer's Disease
- ABBV-2001Phase 21 trial
AbbVie · Multiple Myeloma
Recruiting Phase 3 trials
Largest first.
- A Study to Evaluate the Safety and Effectiveness of Upadacitinib Tablets in Adult and Adolescent Participants With Severe Alopecia AreataPivotal-lookingRecruiting
AbbVieAbbVie (ABBV)
NCT06012240 · 1,500 participants (planned) · Start Oct 11, 2023 · Primary completion Apr 2030
Drug: Upadacitinib; Placebo · For: Alopecia Areata
Sites: Birmingham, Alabama; Glendale, Arizona; Phoenix, Arizona · 272 sites in all
- Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)Pivotal-lookingRecruiting
AbbVieAbbVie (ABBV)
NCT05125302 · 1,059 participants (planned) · Start Jan 13, 2022 · Primary completion May 2027
Drug: Ubrogepant; Placebo-Matching Ubrogepant · For: Migraine
Sites: Huntsville, Alabama; Saraland, Alabama; Phoenix, Arizona · 129 sites in all
AbbVieAbbVie (ABBV)
NCT07525206 · 990 participants (planned) · Start May 22, 2026 · Primary completion May 2029
Drug: Telisotuzumab adizutecan; Bevacizumab and 1 more · For: Colorectal Cancer
Sites: Goodyear, Arizona; Springdale, Arkansas; Duarte, California · 91 sites in all
- A Study to Assess Intravenous ABBV-1480 Combined With Chemotherapy Versus Pembrolizumab Combined With Chemotherapy for the First Line Treatment of Locally Advanced/Metastatic Non-Small Cell Lung Cancer in Adult ParticipantsPivotal-lookingRecruiting
AbbVieAbbVie (ABBV)
NCT07756645 · 940 participants (planned) · Start Sep 22, 2026 · Primary completion Dec 2029
Drug: ABBV-1480; Pembrolizumab and 3 more · For: Non-Small Cell Lung Cancer
Sites: Fort Wayne, Indiana; Rio Piedras, Puerto Rico
AbbVieAbbVie (ABBV)
NCT07490301 · 900 participants (planned) · Start Apr 30, 2026 · Primary completion Jun 2031
Drug: Telisotuzumab adizutecan; Fluorouracil and 3 more · For: Metastatic Pancreatic Ductal Adenocarcinoma; PDAC
Sites: New Haven, Connecticut; Chicago, Illinois; Zion, Illinois · 22 sites in all
AbbVieAbbVie (ABBV)
NCT07005102 · 854 participants (planned) · Start Aug 3, 2025 · Primary completion Nov 2036
Drug: Standard of Care; Telisotuzumab Adizutecan and 4 more · For: Non-Squamous Non-Small Cell Lung Cancer; c-MET
Sites: Chandler, Arizona; Duarte, California; Irvine, California · 65 sites in all
- A Study to Assess Disease Activity and Adverse Events of Intravenous (IV) Telisotuzumab Vedotin Compared to IV Docetaxel in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)Pivotal-lookingRecruiting
AbbVieAbbVie (ABBV)
NCT04928846 · 768 participants (planned) · Start Mar 25, 2022 · Primary completion Dec 2028
Drug: Telisotuzumab Vedotin; Docetaxel · For: Non Small Cell Lung Cancer; c-MET
Sites: Birmingham, Alabama; Chandler, Arizona; Phoenix, Arizona · 317 sites in all
AbbVieAbbVie (ABBV)
NCT07095452 · 680 participants (planned) · Start Jan 8, 2026 · Primary completion Mar 2041
Drug: Etentamig; Lenalidomide and 4 more · For: Multiple Myeloma
Sites: Scottsdale, Arizona; Los Angeles, California; Denver, Colorado · 49 sites in all
AbbVieAbbVie (ABBV)
NCT07581002 · 660 participants (planned) · Start Jun 30, 2026 · Primary completion Jun 2032
Drug: Pivekimab Sunirine; Venetoclax and 2 more · For: Acute Myeloid Leukemia
Sites: Duarte, California; Tampa, Florida; Atlanta, Georgia · 40 sites in all
- Surabgene Lomparvovec Administered in the Suprachoroidal Space in Adult Participants With Diabetic Retinopathy Without Center-Involved Diabetic Macular EdemaPivotal-lookingRecruiting
AbbVieAbbVie (ABBV)
NCT07592273 · 576 participants (planned) · Start Jun 1, 2026 · Primary completion Jun 2028
Drug: Surabgene Lomparvovec; Sham and 2 more · For: Diabetic Retinopathy
Sites: Mesa, Arizona; Phoenix, Arizona; Scottsdale, Arizona · 40 sites in all
Marketed drugs (83)
Newest FDA action first.
- Skyrizi Risankizumab-Rzaa · 2019
- Skyrizi Risankizumab-Rzaa · 2022
- Canasa Mesalamine · 2001
- Juvmo Tavapadon · 2026
- Kybella Deoxycholic Acid · 2015
- Kaletra Lopinavir, Ritonavir · 2005
- Norvir Ritonavir · 2010
- Norvir Ritonavir · 2017
- Kaletra Lopinavir, Ritonavir · 2000
- Rinvoq Upadacitinib · 2019
- Rinvoq Lq Upadacitinib · 2024
- Decnupaz Pivekimab Sunirine-Pvzy · 2026
- Linzess Linaclotide · 2012
- Venclexta Venetoclax · 2016
- Depakote Er Divalproex Sodium · 2000
- Depakote Divalproex Sodium · 1989
- Depakote Divalproex Sodium · 1983
- Duopa Carbidopa, Levodopa · 2015
- Vyalev Foscarbidopa, Foslevodopa · 2024
- Combigan Brimonidine Tartrate, Timolol Maleate · 2007
- Ozurdex Dexamethasone · 2009
- Humira Adalimumab · 2002
- Vraylar Cariprazine Hydrochloride · 2015
- Oriahnn (Copackaged) Elagolix Sodium,Estradiol,Norethindrone Acetate, Elagolix Sodium · 2020
- Orilissa Elagolix Sodium · 2018
- Pred Mild Prednisolone Acetate · 1972
- Lupron Depot-Ped Kit Leuprolide Acetate · 1993
- Imbruvica Ibrutinib · 2022
- Imbruvica Ibrutinib · 2018
- Imbruvica Ibrutinib · 2013
- Qulipta Atogepant · 2021
- Alphagan P Brimonidine Tartrate · 2001
- Acular Ketorolac Tromethamine · 1992
- Alphagan P Brimonidine Tartrate · 2005
- Lupron Depot Leuprolide Acetate · 1997
- Lupron Depot Leuprolide Acetate · 1995
- Savella Milnacipran Hydrochloride · 2009
- Lupron Depot Leuprolide Acetate · 1990
- Restasis Multidose Cyclosporine · 2002
- Lupron Depot Leuprolide Acetate · 1995
- Lupron Depot Leuprolide Acetate · 1989
- Mavyret Glecaprevir, Pibrentasvir · 2021
- Mavyret Glecaprevir, Pibrentasvir · 2017
- Ubrelvy Ubrogepant · 2019
- Emrelis Telisotuzumab Vedotin-Tllv · 2025
- Avycaz Avibactam Sodium, Ceftazidime · 2015
- Fml Forte Fluorometholone · 1986
- Emblaveo Avibactam Sodium, Aztreonam · 2025
- Ultane Sevoflurane · 1995
- Saphris Asenapine Maleate · 2009
- Dalvance Dalbavancin Hydrochloride · 2014
- Botox Cosmetic Onabotulinumtoxina · 1991
- Durysta Bimatoprost · 2020
- Infed Iron Dextran · 1974
- Oxytrol Oxybutynin · 2003
- Acuvail Ketorolac Tromethamine · 2009
- Lexapro Escitalopram Oxalate · 2002
- Fetzima Levomilnacipran Hydrochloride · 2013
- Viibryd Vilazodone Hydrochloride · 2011
- Celexa Citalopram Hydrobromide · 1998
- Creon Pancrelipase (Amylase, Lipase, Protease) · 2009
- Synthroid Levothyroxine Sodium · 2002
- Bystolic Nebivolol Hydrochloride · 2007
- Zemplar Paricalcitol · 1998
- Lastacaft Alcaftadine · 2010
- Survanta Beractant · 1991
- Lumigan Bimatoprost · 2010
- Teflaro Ceftaroline Fosamil · 2010
- Latisse Bimatoprost · 2008
- Acular Ls Ketorolac Tromethamine · 2003
- Viberzi Eluxadoline · 2015
- Pred Forte Prednisolone Acetate · 1973
- Betagan Levobunolol Hydrochloride · 1985
- Ocuflox Ofloxacin · 1993
- Zymaxid Gatifloxacin · 2010
- Namzaric Donepezil Hydrochloride, Memantine Hydrochloride · 2014
- Oxytrol For Women Oxybutynin · 2013
- Crinone Progesterone · 1997
- Carafate Sucralfate · 1981
- Fml Fluorometholone · 1972
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.